Oral Spray Vaccine Offers Prolonged UTI Protection!
More than 50% of individuals who received the oral spray vaccine remained free of urinary tract infections.
Stay updated with breaking news from Bob Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than 50% of individuals who received the oral spray vaccine remained free of urinary tract infections.
A new oral vaccine could prove a potential alternative to antibiotics for people with recurring urinary tract infections, a new study says.
At the European Association of Urology Congress in Paris, a recent study was presented unveiling the initial findings of the first long-term follow-up study on the Uromune (MV140) inactivated vaccine developed by the Madrid-based Immunotek S.
Research has found the treatment can prevent urinary tract infections (UTIs) for up to nine years in more than half of patients. The vaccine is given as a pineapple- flavoured oral spray.
Each year UTI infection leads to 150,000 hospitalisations, costing the NHS £380 million annually - during the study the average infection-free period was four and a half years)